Acclarent
About:
Acclarent is a medical device company that develops new technologies to treat patients suffering from ENT disorders.
Website: http://www.acclarent.com
Twitter/X: Acclarent_ENT
Top Investors: New Enterprise Associates, Meritech Capital Partners, ExploraMed, Versant Ventures, Johnson & Johnson Development Corporation
Description:
Acclarent, Inc. is a medical device company. The company is dedicated to the development of innovative devices providing new technologies to further meet the needs of ENT patients. Acclarent's initial focus is on achieving the goals of sinus surgery with novel, endoscopic, catheter-based tools—Balloon Sinuplasty® devices. Through the Balloon SinuplastyTM technology and the company's RelievaTM registered product portfolio, we offer ENT patients alternatives to conventional endoscopic surgical approaches. FDA clearances for these devices were completed in 2005, and the products were commercially launched in the US that same year.
$86M
$100M to $500M
Menlo Park, California, United States
2004-06-01
acclarent(AT)acclarent.com
John Chang, Josh Makower
251-500
2009-01-12
Private
© 2025 bioDAO.ai